Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?

Melinda Davis, Paul Shafer, Stephanie Renfro, Kristen Hassmiller Lich, Jackilen (Jackie) Shannon, Gloria D. Coronado, Kenneth (John) McConnell, Stephanie B. Wheeler

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

BACKGROUND: Health care reform is changing preventive services delivery. This study explored trajectories in colorectal cancer (CRC) testing over a 5-year period that included implementation of 16 Medicaid Accountable Care Organizations (ACOs, 2012) and Medicaid expansion (2014) - two provisions of the Affordable Care Act (ACA) - within the state of Oregon, USA. METHODS: Retrospective analysis of Oregon's Medicaid claims for enrollee's eligible for CRC screening (50-64 years) spanning January 2010 through December 2014. Our analysis was conducted and refined April 2016 through June 2018. The analysis assessed the annual probability of patients receiving CRC testing and the modality used (e.g., colonoscopy, fecal testing) relative to a baseline year (2010). We hypothesized that CRC testing would increase following Medicaid ACO formation - called Coordinated Care Organizations (CCOs). RESULTS: A total of 132,424 unique Medicaid enrollees (representing 255,192 person-years) met inclusion criteria over the 5-year study. Controlling for demographic and regional factors, the predicted probability of CRC testing was significantly higher in 2014 (+ 1.4 percentage points, p < 0.001) compared to the 2010 baseline but not in 2012 or 2013. Increased fecal testing using Fecal Occult Blood Tests (FOBT) or Fecal Immunochemical Tests (FIT) played a prominent role in 2014. The uptick in statewide fecal testing appears driven primarily by a subset of CCOs. CONCLUSIONS: Observed CRC testing did not immediately increase following the transition to CCOs in 2012. However increased testing in 2014, may reflect a delay in implementation of interventions to increase CRC screening and/or a strong desire by newly insured Medicaid CCO members to receive preventive care.

Original languageEnglish (US)
Number of pages1
JournalBMC Health Services Research
Volume19
Issue number1
DOIs
StatePublished - Jan 21 2019

Fingerprint

Medicaid
Colorectal Neoplasms
Organizations
Early Detection of Cancer
Accountable Care Organizations
Patient Protection and Affordable Care Act
Occult Blood
Preventive Medicine
Health Care Reform
Hematologic Tests
Colonoscopy
Demography

Keywords

  • Accountable care organizations
  • Colorectal cancer
  • Disparities
  • Medicaid

ASJC Scopus subject areas

  • Health Policy

Cite this

Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing? / Davis, Melinda; Shafer, Paul; Renfro, Stephanie; Hassmiller Lich, Kristen; Shannon, Jackilen (Jackie); Coronado, Gloria D.; McConnell, Kenneth (John); Wheeler, Stephanie B.

In: BMC Health Services Research, Vol. 19, No. 1, 21.01.2019.

Research output: Contribution to journalArticle

Davis, Melinda ; Shafer, Paul ; Renfro, Stephanie ; Hassmiller Lich, Kristen ; Shannon, Jackilen (Jackie) ; Coronado, Gloria D. ; McConnell, Kenneth (John) ; Wheeler, Stephanie B. / Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?. In: BMC Health Services Research. 2019 ; Vol. 19, No. 1.
@article{0e8cec5984a8464385bb8688359c83fc,
title = "Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?",
abstract = "BACKGROUND: Health care reform is changing preventive services delivery. This study explored trajectories in colorectal cancer (CRC) testing over a 5-year period that included implementation of 16 Medicaid Accountable Care Organizations (ACOs, 2012) and Medicaid expansion (2014) - two provisions of the Affordable Care Act (ACA) - within the state of Oregon, USA. METHODS: Retrospective analysis of Oregon's Medicaid claims for enrollee's eligible for CRC screening (50-64 years) spanning January 2010 through December 2014. Our analysis was conducted and refined April 2016 through June 2018. The analysis assessed the annual probability of patients receiving CRC testing and the modality used (e.g., colonoscopy, fecal testing) relative to a baseline year (2010). We hypothesized that CRC testing would increase following Medicaid ACO formation - called Coordinated Care Organizations (CCOs). RESULTS: A total of 132,424 unique Medicaid enrollees (representing 255,192 person-years) met inclusion criteria over the 5-year study. Controlling for demographic and regional factors, the predicted probability of CRC testing was significantly higher in 2014 (+ 1.4 percentage points, p < 0.001) compared to the 2010 baseline but not in 2012 or 2013. Increased fecal testing using Fecal Occult Blood Tests (FOBT) or Fecal Immunochemical Tests (FIT) played a prominent role in 2014. The uptick in statewide fecal testing appears driven primarily by a subset of CCOs. CONCLUSIONS: Observed CRC testing did not immediately increase following the transition to CCOs in 2012. However increased testing in 2014, may reflect a delay in implementation of interventions to increase CRC screening and/or a strong desire by newly insured Medicaid CCO members to receive preventive care.",
keywords = "Accountable care organizations, Colorectal cancer, Disparities, Medicaid",
author = "Melinda Davis and Paul Shafer and Stephanie Renfro and {Hassmiller Lich}, Kristen and Shannon, {Jackilen (Jackie)} and Coronado, {Gloria D.} and McConnell, {Kenneth (John)} and Wheeler, {Stephanie B.}",
year = "2019",
month = "1",
day = "21",
doi = "10.1186/s12913-018-3864-5",
language = "English (US)",
volume = "19",
journal = "BMC Health Services Research",
issn = "1472-6963",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - Does a transition to accountable care in Medicaid shift the modality of colorectal cancer testing?

AU - Davis, Melinda

AU - Shafer, Paul

AU - Renfro, Stephanie

AU - Hassmiller Lich, Kristen

AU - Shannon, Jackilen (Jackie)

AU - Coronado, Gloria D.

AU - McConnell, Kenneth (John)

AU - Wheeler, Stephanie B.

PY - 2019/1/21

Y1 - 2019/1/21

N2 - BACKGROUND: Health care reform is changing preventive services delivery. This study explored trajectories in colorectal cancer (CRC) testing over a 5-year period that included implementation of 16 Medicaid Accountable Care Organizations (ACOs, 2012) and Medicaid expansion (2014) - two provisions of the Affordable Care Act (ACA) - within the state of Oregon, USA. METHODS: Retrospective analysis of Oregon's Medicaid claims for enrollee's eligible for CRC screening (50-64 years) spanning January 2010 through December 2014. Our analysis was conducted and refined April 2016 through June 2018. The analysis assessed the annual probability of patients receiving CRC testing and the modality used (e.g., colonoscopy, fecal testing) relative to a baseline year (2010). We hypothesized that CRC testing would increase following Medicaid ACO formation - called Coordinated Care Organizations (CCOs). RESULTS: A total of 132,424 unique Medicaid enrollees (representing 255,192 person-years) met inclusion criteria over the 5-year study. Controlling for demographic and regional factors, the predicted probability of CRC testing was significantly higher in 2014 (+ 1.4 percentage points, p < 0.001) compared to the 2010 baseline but not in 2012 or 2013. Increased fecal testing using Fecal Occult Blood Tests (FOBT) or Fecal Immunochemical Tests (FIT) played a prominent role in 2014. The uptick in statewide fecal testing appears driven primarily by a subset of CCOs. CONCLUSIONS: Observed CRC testing did not immediately increase following the transition to CCOs in 2012. However increased testing in 2014, may reflect a delay in implementation of interventions to increase CRC screening and/or a strong desire by newly insured Medicaid CCO members to receive preventive care.

AB - BACKGROUND: Health care reform is changing preventive services delivery. This study explored trajectories in colorectal cancer (CRC) testing over a 5-year period that included implementation of 16 Medicaid Accountable Care Organizations (ACOs, 2012) and Medicaid expansion (2014) - two provisions of the Affordable Care Act (ACA) - within the state of Oregon, USA. METHODS: Retrospective analysis of Oregon's Medicaid claims for enrollee's eligible for CRC screening (50-64 years) spanning January 2010 through December 2014. Our analysis was conducted and refined April 2016 through June 2018. The analysis assessed the annual probability of patients receiving CRC testing and the modality used (e.g., colonoscopy, fecal testing) relative to a baseline year (2010). We hypothesized that CRC testing would increase following Medicaid ACO formation - called Coordinated Care Organizations (CCOs). RESULTS: A total of 132,424 unique Medicaid enrollees (representing 255,192 person-years) met inclusion criteria over the 5-year study. Controlling for demographic and regional factors, the predicted probability of CRC testing was significantly higher in 2014 (+ 1.4 percentage points, p < 0.001) compared to the 2010 baseline but not in 2012 or 2013. Increased fecal testing using Fecal Occult Blood Tests (FOBT) or Fecal Immunochemical Tests (FIT) played a prominent role in 2014. The uptick in statewide fecal testing appears driven primarily by a subset of CCOs. CONCLUSIONS: Observed CRC testing did not immediately increase following the transition to CCOs in 2012. However increased testing in 2014, may reflect a delay in implementation of interventions to increase CRC screening and/or a strong desire by newly insured Medicaid CCO members to receive preventive care.

KW - Accountable care organizations

KW - Colorectal cancer

KW - Disparities

KW - Medicaid

UR - http://www.scopus.com/inward/record.url?scp=85060209484&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060209484&partnerID=8YFLogxK

U2 - 10.1186/s12913-018-3864-5

DO - 10.1186/s12913-018-3864-5

M3 - Article

C2 - 30665396

AN - SCOPUS:85060209484

VL - 19

JO - BMC Health Services Research

JF - BMC Health Services Research

SN - 1472-6963

IS - 1

ER -